International Journal of Clinical Pharmacy

, Volume 36, Issue 4, pp 697–701 | Cite as

Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation

  • Eline TommeleinEmail author
  • Kathleen Tollenaere
  • Els Mehuys
  • Koen Boussery
Short Research Report


Background A protocol-based pharmaceutical care program (the PHARMACOP-protocol) focusing on patient counselling during prescription filling has shown to be effective in patients with chronic obstructive pulmonary disease (COPD). However, implementation of this protocol in daily practice has not yet been studied. Objective To describe current implementation level of the items included in the PHARMACOP-protocol in Belgian community pharmacies and to evaluate pharmacists' perspectives on the implementation of this protocol in daily practice. Method A cross-sectional study was conducted from April to June 2012, in randomly selected community pharmacies in Flanders. Pharmacists were questionned using structured interviews. Results 125 pharmacies were contacted and 80 managing pharmacists (64 %) participated. In >70 % of pharmacies, 4/7 protocol items for first prescriptions and 3/5 protocol items for follow-up prescriptions were already routinely implemented. For first and follow-up prescriptions, respectively 39 (49 %) and 34 pharmacists (43 %) stated they would need to spend at least 5 min extra to offer optimal patient counselling. Most mentioned barriers preventing protocol implementation included lack of time (80 %), no integration in pharmacy software (61 %) and too much administrative burden (58 %). Conclusion Approximately 50 % of the PHARMACOP-protocol items are currently routinely provided in Belgian community pharmacies. Nearly all interviewed pharmacists are willing to implement the protocol fully or partially in daily practice.


Pharmaceutical care Belgium COPD PHARMACOP Community pharmacy 



We thank all community pharmacists, participating in this study. Pharmacists did not receive compensation for their contribution.



Conflicts of interest



  1. 1.
    Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.; Global Initiative for chronic Obstructive Lung Disease 2011. Accessed 12 Mar 2014.
  2. 2.
    Brown P, Bluml BM, Kritzler R, Petryna M, Polley CM, Tietze KJ, et al. White paper on expanding the role of pharmacists in chronic obstructive pulmonary disease. J Am Pharm Assoc. 2011;51(2):203–11.CrossRefGoogle Scholar
  3. 3.
    Tommelein E, Mehuys E, Van Hees T, Adriaens E, Van Bortel L, Christiaens T, et al. Effectiveness of PHARMAceutical care for patients with COPD (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756-66.Google Scholar
  4. 4.
    Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction (Abingdon, England). 2001;96(2):325–31.CrossRefGoogle Scholar
  5. 5.
    von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRefGoogle Scholar
  6. 6.
    van Hulten R, Blom L, Mattheusens J, Wolters M, Bouvy M. Communication with patients who are dispensed a first prescription of chronic medication in the community pharmacy. Patient Educ Couns. 2011;83(3):417–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Stoilkova A, Janssen DJ, Wouters EF. Educational programmes in COPD management interventions: a systematic review. Respir Med. 2013;107(11):1637–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med. 1999;160(6):2000–5.PubMedGoogle Scholar
  9. 9.
    ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997;54(4):431–4.Google Scholar
  10. 10.
    Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. Int J Clin Pharm. 2012;34(3):452–9.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Eline Tommelein
    • 1
    Email author
  • Kathleen Tollenaere
    • 1
  • Els Mehuys
    • 1
  • Koen Boussery
    • 1
  1. 1.Pharmaceutical Care Unit, Faculty of Pharmaceutical SciencesGhent UniversityGhentBelgium

Personalised recommendations